glp-1 drugs in development Emerging Trends the of Receptor Agonists GLP-1 Pipeline Update: February 2025

Meister, A., Glutathione-Ascorbic Acid Antioxidant System in Animals

So if you can have genetic pathways that are basically toning down pro-inflammatory cytokines and bumping up anti-inflammatory pathways and, you know, bumping up antioxidant pathways in our bodies, also helping with stem-cell production and helping with our proteins folding normally so we dont have aggregates building up, like you can activate those pathways by doing things like exercising and eating some of these flavonols and polyphenols and also by, you know, fasting

Available at: Accessed 7/18/2012

Li, Z., Chen, Z., Chen, H., Chen, K., Tao, W., Ouyang, X.-k.,..., & Zeng, X

Genetics: Genetic mutations are significant in forms like early-onset Alzheimers and frontotemporal dementia, with a strong familial link